Drexel University was awarded a $302,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 2021 through March 2024 to develop a novel microtubule-based hypothesis for frontotemporal dementia leading to potential therapies for military personnel and veterans. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform...
This federal Project Grant award of $437,967.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, San Diego (UCSD) focused on arterial disease in vascular Ehlers-Danlos syndrome and the potential role of oxidative stress. The award, effective January 1, 2025 through December 31, 2026, will fund comprehensive research services and scientific investigations at UCSD, a renowned...
The University of Florida was awarded a $152,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 1, 2025, supports advanced biomedical research aimed at "Targeting TIE2 as a Novel Strategy in VEGFR Inhibitor-Resistant Angiosarcoma" with a performance period ending on July 31, 2027. The Military Medical Research and Development program funds a diverse portfolio of scientific...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
This federal Project Grant award of $1,592,860.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The award was granted to the Rector & Visitors of the University of Virginia, a prominent academic research institution, to conduct ultrasensitive proteomics research for type 1 diabetes prediction and treatment efficacy...
The U.S. Defense Health Agency awarded a $1,999,996 Project Grant to Temple University under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to identify diagnostic biomarkers of cerebrovascular contributions to cognitive impairment in repeated blast concussion. This 4-year research project, running from June 2025 to May 2029, aims to transform healthcare for military service members, veterans, and the broader public by...
The University of Virginia (UVA) received a $847,875 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, effective September 1, 2025 through August 31, 2028, will support research targeting Schwann cell-tumor microenvironment interactions in neurofibroma development. The federal grant funding will enable UVA to conduct advanced biomedical research aimed at transforming healthcare for military service members,...
The University of Florida was awarded a $1,166,594 project grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "EARLY CARDIAC BIOMARKERS OF INFLAMMATION AND REMODELING IN DMD," will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The project will investigate innovative approaches to address critical health challenges related...
The University of Delaware was awarded a $2,000,000 Cooperative Agreement under the Department of Defense Basic Scientific Research program (CFDA 12.431) with a performance period from October 1, 2024 to September 30, 2025. The award supports foundational and applied research across diverse scientific and technical domains critical to national security, with a focus on advancing innovative capabilities in areas such as quantum computing, artificial intelligence, materials science, robotics,...
The University of Toledo received a $1.7 million project grant award from the Defense Health Agency on September 15, 2021 to complete work by August 14, 2025. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care. Specifically, the University will investigate maladaptive nigrovagal pathophysiology in parkinsonism under this award. The research aims to...